Literature DB >> 2079579

Ambulatory infusion devices in the continuing care of patients with advanced diseases.

E Bruera.   

Abstract

Until recently, patients who required hydration or parenteral administration of narcotics or antiemetics remained in hospitals until death. The period of admission, which varied between days and months, resulted in a decreased quality of life for the patient and family. With the development of portable infusion pumps, patients with these needs can now be safely discharged home for long periods of time, thereby significantly reducing the cost of medical care and improving quality of life for patients and families. The demonstration that the subcutaneous route is safe and effective for the administration of narcotics, antiemetics, and fluids has made home discharges particularly easy and simple. New devices even allow patients to self-administer extra doses of narcotics when needed. Each institution needs to carefully consider the different infusion devices available before starting a home parenteral administration program. The most important factors to consider are cost, health professional education, patient and family education, a system of monitoring in the home and safety. The high cost of portable pumps and supplies are a major obstacle for the establishment of large programs for home parenteral drug administration. More research is needed to better characterize the pharmacokinetics of different drugs when administered subcutaneously, and to develop simpler and more effective portable infusion devices. The results of this research will have a major impact on the quality of life of patients and their families.

Entities:  

Mesh:

Year:  1990        PMID: 2079579     DOI: 10.1016/0885-3924(90)90045-l

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  7 in total

Review 1.  Management strategies for chronic pain.

Authors:  D M Justins
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

2.  Stability and compatibility of binary mixtures of morphine hydrochloride with hyoscine-n-butyl bromide.

Authors:  Emilia Barcia; Rodrigo Reyes; Maria Luz Azuara; Yolanda Sánchez; Sofía Negro
Journal:  Support Care Cancer       Date:  2004-11-18       Impact factor: 3.603

3.  [Patient-controlled analgesia (PCA) in outpatients with cancer pain. Analysis of 1,692 treatment days].

Authors:  C Schiessl; J Bidmon; R Sittl; N Griessinger; J Schüttler
Journal:  Schmerz       Date:  2007-02       Impact factor: 1.107

4.  The Safety and Effectiveness of Patient-controlled Analgesia in Outpatient Children and Young Adults With Cancer: A Retrospective Study.

Authors:  Doralina L Anghelescu; Kelly Zhang; Lane G Faughnan; Deqing Pei
Journal:  J Pediatr Hematol Oncol       Date:  2015-07       Impact factor: 1.289

5.  [Patient-controlled analgesia in outpatients with severe cancer pain.].

Authors:  M Herbst; H Goeke
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

Review 6.  Ethical dilemmas in hospice and palliative care.

Authors:  B M Kinzbrunner
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

7.  The flow Rate Accuracy of Elastomeric Infusion Pumps After Repeated Filling.

Authors:  Masood Mohseni; Amin Ebneshahidi
Journal:  Anesth Pain Med       Date:  2014-04-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.